Frequency of the D620N Mutation in VPS35 in Parkinson Disease

被引:63
作者
Kumar, Kishore R. [2 ,5 ,6 ]
Weissbach, Anne [1 ,2 ]
Heldmann, Marcus [1 ]
Kasten, Meike [2 ]
Tunc, Sinem [2 ]
Sue, Carolyn M. [5 ,6 ]
Svetel, Marina [7 ]
Kostic, Vladimir S. [7 ]
Segura-Aguilar, Juan [8 ]
Ramirez, Alfredo [2 ,3 ]
Simon, David K. [9 ,10 ]
Vieregge, Peter [4 ]
Muente, Thomas F. [1 ]
Hagenah, Johann [1 ,2 ]
Klein, Christine [2 ]
Lohmann, Katja [2 ]
机构
[1] Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany
[2] Univ Lubeck, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany
[3] Univ Hosp Bonn, Dept Psychiat, Bonn, Germany
[4] Hosp Lippe Lemgo, Dept Neurol, Lemgo, Germany
[5] Royal N Shore Hosp, Kolling Inst Med Res, Dept Neurogenet, Sydney, NSW, Australia
[6] Univ Sydney, Sydney, NSW 2006, Australia
[7] Univ Belgrade, Sch Med, Inst Neurol CCS, Belgrade, Serbia
[8] Univ Chile, Sch Med, ICBM, Santiago, Chile
[9] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA
[10] Harvard Univ, Sch Med, Boston, MA USA
基金
英国医学研究理事会;
关键词
COGNITIVE IMPAIRMENT; PHENOTYPE;
D O I
10.1001/archneurol.2011.3367
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To evaluate the frequency and clinical spectrum of the recently identified p.D620N mutation in the VPS35 gene in Parkinson disease (PD) in an international sample. Design: Genetic analysis by DNA sequencing and detailed clinical and neuropsychiatric assessment as well as neuroimaging in mutation carriers. Setting: Tertiary referral centers in Germany, Serbia, Chile, and the United States. Patients: One thousand seven hundred seventy-four patients with PD. Main Outcome Measure: Frequency of the p.D620N mutation. Results: A single mutation carrier was identified. The mutation carrier was a 60-year-old German man who had tremor-dominant PD since the age of 45 years. Longitudinal follow-up over 13 years revealed a disease progression from Hoehn and Yahr stage 1 to 3. There was evidence of mild cognitive impairment on the Montreal Cognitive Assessment. No abnormalities were observed by multimodal neuroimaging. He had a family history consistent with autosomal dominant inheritance. An affected paternal aunt and 3 reportedly unaffected siblings were also found to be mutation carriers. Conclusion: VPS35 mutations are a rare cause of PD in different populations. The clinical phenotype may be indistinguishable from idiopathic PD with the possible exception of an earlier age at onset. Genetic analysis of the extended family revealed incomplete penetrance of the p.D620N mutation. Arch Neurol. 2012;69(10):1360-1364. Published online July 16, 2012. doi:10.1001/archneurol.2011.3367
引用
收藏
页码:1360 / 1364
页数:5
相关论文
共 14 条
[1]   Mild cognitive impairment in Parkinson disease A multicenter pooled analysis [J].
Aarsland, D. ;
Bronnick, K. ;
Williams-Gray, C. ;
Weintraub, D. ;
Marder, K. ;
Kulisevsky, J. ;
Burn, D. ;
Barone, P. ;
Pagonabarraga, J. ;
Allcock, L. ;
Santangelo, G. ;
Foltynie, T. ;
Janvin, C. ;
Larsen, J. P. ;
Barker, R. A. ;
Emre, M. .
NEUROLOGY, 2010, 75 (12) :1062-1069
[2]  
Becker G, 2001, MOVEMENT DISORD, V16, P23, DOI 10.1002/1531-8257(200101)16:1<23::AID-MDS1003>3.0.CO
[3]  
2-2
[4]   Alpha-synuclein and Parkinson's disease:: Implications from the screening of more than 1,900 patients [J].
Berg, D ;
Niwar, M ;
Maass, S ;
Zimprich, A ;
Möller, JC ;
Wuellner, U ;
Schmitz-Hübsch, T ;
Klein, C ;
Tan, EK ;
Schöls, L ;
Marsh, L ;
Dawson, TM ;
Janetzky, B ;
Müller, T ;
Woitalla, D ;
Kostic, V ;
Pramstaller, PP ;
Oertel, WH ;
Bauer, P ;
Krueger, R ;
Gasser, T ;
Riess, O .
MOVEMENT DISORDERS, 2005, 20 (09) :1191-1194
[5]   Retrograde transport from endosomes to the trans-Golgi network [J].
Bonifacino, Juan S. ;
Rojas, Raul .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (08) :568-579
[6]   Recessively Inherited Parkinsonism Effect of ATP13A2 Mutations on the Clinical and Neuroimaging Phenotype [J].
Brueggemann, Norbert ;
Hagenah, Johann ;
Reetz, Kathrin ;
Schmidt, Alexander ;
Kasten, Meike ;
Buchmann, Inga ;
Eckerle, Susanne ;
Baehre, Manfred ;
Muenchau, Alexander ;
Djarmati, Ana ;
van der Vegt, Joyce ;
Siebner, Hartwig ;
Binkofski, Ferdinand ;
Ramirez, Alfredo ;
Behrens, Maria I. ;
Klein, Christine .
ARCHIVES OF NEUROLOGY, 2010, 67 (11) :1357-1363
[7]   The MoCA Well-suited screen for cognitive impairment in Parkinson disease [J].
Dalrymple-Alford, J. C. ;
MacAskill, M. R. ;
Nakas, C. T. ;
Livingston, L. ;
Graham, C. ;
Crucian, G. P. ;
Melzer, T. R. ;
Kirwan, J. ;
Keenan, R. ;
Wells, S. ;
Porter, R. J. ;
Watts, R. ;
Anderson, T. J. .
NEUROLOGY, 2010, 75 (19) :1717-1725
[8]   Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study [J].
Healy, Daniel G. ;
Falchi, Mario ;
O'Sullivan, Sean S. ;
Bonifati, Vincenzo ;
Durr, Alexandra ;
Bressman, Susan ;
Brice, Alexis ;
Aasly, Jan ;
Zabetian, Cyrus P. ;
Goldwurm, Stefano ;
Ferreira, Joaquim J. ;
Tolosa, Eduardo ;
Kay, Denise M. ;
Klein, Christine ;
Williams, David R. ;
Marras, Connie ;
Lang, Anthony E. ;
KWszolek, Zbigniew ;
Berciano, Jose ;
Schapira, Anthony H. V. ;
Lynch, Timothy ;
Bhatia, Kailash P. ;
Gasser, Thomas ;
Lees, Andrew J. ;
Wood, Nicholas W. .
LANCET NEUROLOGY, 2008, 7 (07) :583-590
[9]   Recurrent LRRK2 (Park8) mutations in early-onset Parkinson's disease [J].
Hedrich, Katja ;
Winkler, Susen ;
Hagenah, Johann ;
Kabakci, Kemal ;
Kasten, Meike ;
Schwinger, Eberhard ;
Volkmann, Jens ;
Pramstaller, Peter P. ;
Kostic, Vladimir ;
Vieregge, Peter ;
Klein, Christine .
MOVEMENT DISORDERS, 2006, 21 (09) :1506-1510
[10]   Role of parkin mutations in 111 community-based patients with early-onset parkinsonism [J].
Kann, M ;
Jacobs, H ;
Mohrmann, K ;
Schumacher, K ;
Hedrich, K ;
Garrels, J ;
Wiegers, K ;
Schwinger, E ;
Pramstaller, PP ;
Breakefield, XO ;
Ozelius, LJ ;
Vieregge, P ;
Klein, C .
ANNALS OF NEUROLOGY, 2002, 51 (05) :621-625